Page last updated: 2024-09-03

mk 0663 and desoxycorticosterone acetate

mk 0663 has been researched along with desoxycorticosterone acetate in 1 studies

Compound Research Comparison

Studies (mk 0663)	Trials (mk 0663)	Recent Studies (post-2010) (mk 0663)	Studies (desoxycorticosterone acetate)	Trials (desoxycorticosterone acetate)	Recent Studies (post-2010) (desoxycorticosterone acetate)
549	173	265	692	0	231

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agarwal, M; Chugh, PK; Gupta, M; Tekur, U	1

Other Studies

1 other study(ies) available for mk 0663 and desoxycorticosterone acetate

Article	Year
Etoricoxib attenuates effect of antihypertensives in a rodent model of DOCA-salt induced hypertension. Clinical and experimental hypertension (New York, N.Y. : 1993), 2013, Volume: 35, Issue:8 Topics: Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Blood Pressure; Cyclooxygenase 2 Inhibitors; Desoxycorticosterone Acetate; Disease Models, Animal; Etoricoxib; Hypertension; Mineralocorticoids; Pyridines; Ramipril; Rats; Rats, Sprague-Dawley; Sodium Chloride; Sulfones; Telmisartan	2013

Article

Year

Etoricoxib attenuates effect of antihypertensives in a rodent model of DOCA-salt induced hypertension.

Clinical and experimental hypertension (New York, N.Y. : 1993), 2013, Volume: 35, Issue:8

Topics: Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Blood Pressure; Cyclooxygenase 2 Inhibitors; Desoxycorticosterone Acetate; Disease Models, Animal; Etoricoxib; Hypertension; Mineralocorticoids; Pyridines; Ramipril; Rats; Rats, Sprague-Dawley; Sodium Chloride; Sulfones; Telmisartan

2013